Skip to content
Artemis II Moon Mission
3APR

Crew's Own Cells Fly to the Moon as Living Experiments

1 min read
12:59UTC

Organ-on-chip devices grown from each astronaut's bone marrow will produce the first personalised deep-space radiation data.

ScienceDeveloping
Key takeaway

Personalised organ-on-chip experiments will yield the first individualised deep-space radiation data.

4 organ-on-chip devices aboard Orion contain cells grown from each crew member's own bone marrow as part of the AVATAR (Virtual Astronaut Tissue Analog Response) experiment 1. Partners include BARDA, the NIH, and the Wyss Institute at Harvard. The chips are microfluidic devices that mimic human organ tissue at small scale. Exposing them to deep-space radiation alongside the crew members who donated the cells produces the first individualised dataset on how that radiation affects human biology. Previous space radiation studies relied on generic tissue samples or animal models. The data will inform dosage limits, shielding requirements, and medical protocols for longer missions. For a programme whose critics question its scientific return, these chips represent concrete research that could not be conducted anywhere closer to Earth.

Deep Analysis

In plain English

Each astronaut donated some of their bone marrow cells before the mission. Scientists grew those cells into tiny devices called organ-on-chips: microfluidic chips the size of a USB drive that mimic how human organs behave. These chips are flying alongside the crew members who donated the cells. When both are exposed to the same deep-space radiation environment, scientists can measure exactly how that radiation affects those specific people's biology, not a generic average. This matters because future missions to Mars will expose crews to far more radiation than any previous mission. Understanding individual variation in radiation tolerance could determine crew selection, mission duration, and medical protocols for those journeys.

First Reported In

Update #1 · Artemis II Commits to the Moon With Three Open Questions

Canadian Space Agency· 2 Apr 2026
Read original
Causes and effects
This Event
Crew's Own Cells Fly to the Moon as Living Experiments
These are the first biological experiments in deep space tailored to individual crew members, bridging a gap between generic radiation models and personalised medicine.
Different Perspectives
ESA
ESA
The European Service Module has operated without anomaly for five consecutive days, with the OMS-E engine's translunar injection precision directly responsible for eliminating both correction burns. ESA's hardware contribution is the mission's highest-performing subsystem.
NASA
NASA
NASA cancelled a second consecutive outbound correction burn and confirmed Orion in lunar gravitational dominance, while declining to publish any crew radiation dose data through a complete G3 storm cycle. Bipartisan congressional rejection of its $18.8 billion FY2027 budget proposal means the agency faces a political fight even as its spacecraft performs above expectations.
Dual-framework nations
Dual-framework nations
Signing both the Artemis Accords and the ILRS framework is rational hedging, not defection; smaller nations maximise access without exclusive commitment. Lunar governance is genuinely multipolar, and the US coalition count of 61 overstates exclusivity.
Boeing / Northrop Grumman
Boeing / Northrop Grumman
SLS component production spans more than 40 US states, giving the industrial base strong political protection regardless of commercial alternatives. Congressional mandates guarantee contracts through FY2029, insulating the supply chain from technical programme changes.
NASA Office of Inspector General
NASA Office of Inspector General
The IRB heat shield findings should have been published before launch. The Starship HLS is two years behind schedule with a worsening manual control dispute. NASA has no crew rescue capability for lunar surface operations. The programme is proceeding with documented, unresolved risks.
SpaceX
SpaceX
Starship HLS development is ongoing. SpaceX disputes the characterisation of the manual crew control requirement as unresolved, maintaining its autonomous landing architecture meets mission safety objectives. The company has not publicly responded to the OIG's worsening-trend characterisation.